Cargando…

P1639: UTILITY OF NEXT GENERATION SEQUENCING TECHNIQUES TO EVALUATE POSSIBLE CAUSES OF REFRACTORINESS TO TREATMENT WITH ELTROMBOPAG IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN SPAIN.

Detalles Bibliográficos
Autores principales: Gonzalez-Lopez, T. J., Sanchez, R., Pastoriza, C., Sanchez Gonzalez, B., Olivera, P., Bernat, S., Fernandez-Fuertes, F., Caparrós Miranda, I., Mingot, E., Pérez-Rus, G., Jarque, I., Moreno Beltrán, M. E., López Abadía, E., De Cabo, E., Marcellini, S., Pérez Segura, G., Fernández-Miñano, C., Peñarrubia, M. J., Alvarez, M., Fuertes Palacio, M. A., Martinez Lopez, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430475/
http://dx.doi.org/10.1097/01.HS9.0000849412.72733.8d
_version_ 1784779778530738176
author Gonzalez-Lopez, T. J.
Sanchez, R.
Pastoriza, C.
Sanchez Gonzalez, B.
Olivera, P.
Bernat, S.
Fernandez-Fuertes, F.
Caparrós Miranda, I.
Mingot, E.
Pérez-Rus, G.
Jarque, I.
Moreno Beltrán, M. E.
López Abadía, E.
De Cabo, E.
Marcellini, S.
Pérez Segura, G.
Fernández-Miñano, C.
Peñarrubia, M. J.
Alvarez, M.
Fuertes Palacio, M. A.
Martinez Lopez, J.
author_facet Gonzalez-Lopez, T. J.
Sanchez, R.
Pastoriza, C.
Sanchez Gonzalez, B.
Olivera, P.
Bernat, S.
Fernandez-Fuertes, F.
Caparrós Miranda, I.
Mingot, E.
Pérez-Rus, G.
Jarque, I.
Moreno Beltrán, M. E.
López Abadía, E.
De Cabo, E.
Marcellini, S.
Pérez Segura, G.
Fernández-Miñano, C.
Peñarrubia, M. J.
Alvarez, M.
Fuertes Palacio, M. A.
Martinez Lopez, J.
author_sort Gonzalez-Lopez, T. J.
collection PubMed
description
format Online
Article
Text
id pubmed-9430475
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94304752022-08-31 P1639: UTILITY OF NEXT GENERATION SEQUENCING TECHNIQUES TO EVALUATE POSSIBLE CAUSES OF REFRACTORINESS TO TREATMENT WITH ELTROMBOPAG IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN SPAIN. Gonzalez-Lopez, T. J. Sanchez, R. Pastoriza, C. Sanchez Gonzalez, B. Olivera, P. Bernat, S. Fernandez-Fuertes, F. Caparrós Miranda, I. Mingot, E. Pérez-Rus, G. Jarque, I. Moreno Beltrán, M. E. López Abadía, E. De Cabo, E. Marcellini, S. Pérez Segura, G. Fernández-Miñano, C. Peñarrubia, M. J. Alvarez, M. Fuertes Palacio, M. A. Martinez Lopez, J. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430475/ http://dx.doi.org/10.1097/01.HS9.0000849412.72733.8d Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Gonzalez-Lopez, T. J.
Sanchez, R.
Pastoriza, C.
Sanchez Gonzalez, B.
Olivera, P.
Bernat, S.
Fernandez-Fuertes, F.
Caparrós Miranda, I.
Mingot, E.
Pérez-Rus, G.
Jarque, I.
Moreno Beltrán, M. E.
López Abadía, E.
De Cabo, E.
Marcellini, S.
Pérez Segura, G.
Fernández-Miñano, C.
Peñarrubia, M. J.
Alvarez, M.
Fuertes Palacio, M. A.
Martinez Lopez, J.
P1639: UTILITY OF NEXT GENERATION SEQUENCING TECHNIQUES TO EVALUATE POSSIBLE CAUSES OF REFRACTORINESS TO TREATMENT WITH ELTROMBOPAG IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN SPAIN.
title P1639: UTILITY OF NEXT GENERATION SEQUENCING TECHNIQUES TO EVALUATE POSSIBLE CAUSES OF REFRACTORINESS TO TREATMENT WITH ELTROMBOPAG IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN SPAIN.
title_full P1639: UTILITY OF NEXT GENERATION SEQUENCING TECHNIQUES TO EVALUATE POSSIBLE CAUSES OF REFRACTORINESS TO TREATMENT WITH ELTROMBOPAG IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN SPAIN.
title_fullStr P1639: UTILITY OF NEXT GENERATION SEQUENCING TECHNIQUES TO EVALUATE POSSIBLE CAUSES OF REFRACTORINESS TO TREATMENT WITH ELTROMBOPAG IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN SPAIN.
title_full_unstemmed P1639: UTILITY OF NEXT GENERATION SEQUENCING TECHNIQUES TO EVALUATE POSSIBLE CAUSES OF REFRACTORINESS TO TREATMENT WITH ELTROMBOPAG IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN SPAIN.
title_short P1639: UTILITY OF NEXT GENERATION SEQUENCING TECHNIQUES TO EVALUATE POSSIBLE CAUSES OF REFRACTORINESS TO TREATMENT WITH ELTROMBOPAG IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN SPAIN.
title_sort p1639: utility of next generation sequencing techniques to evaluate possible causes of refractoriness to treatment with eltrombopag in adult patients with primary immune thrombocytopenia (itp) in spain.
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430475/
http://dx.doi.org/10.1097/01.HS9.0000849412.72733.8d
work_keys_str_mv AT gonzalezlopeztj p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT sanchezr p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT pastorizac p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT sanchezgonzalezb p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT oliverap p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT bernats p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT fernandezfuertesf p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT caparrosmirandai p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT mingote p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT perezrusg p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT jarquei p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT morenobeltranme p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT lopezabadiae p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT decaboe p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT marcellinis p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT perezsegurag p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT fernandezminanoc p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT penarrubiamj p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT alvarezm p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT fuertespalacioma p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain
AT martinezlopezj p1639utilityofnextgenerationsequencingtechniquestoevaluatepossiblecausesofrefractorinesstotreatmentwitheltrombopaginadultpatientswithprimaryimmunethrombocytopeniaitpinspain